Format

Send to:

Choose Destination
See comment in PubMed Commons below
Br J Radiol. 2012 Jun;85(1014):697-708. doi: 10.1259/bjr/81120511. Epub 2012 Apr 11.

Watching tumours gasp and die with MRI: the promise of hyperpolarised 13C MR spectroscopic imaging.

Author information

  • 1Department of Biochemistry, University of Cambridge, Cambridge, UK. kmb@mole.bio.cam.ac.uk

Abstract

A better understanding of tumour biology has led to the development of "targeted therapies", in which a drug is designed to disrupt a specific biochemical pathway important for tumour cell survival or proliferation. The introduction of these drugs into the clinic has shown that patients can vary widely in their responses. Molecular imaging is likely to play an increasingly important role in predicting and detecting these responses and thus in guiding treatment in individual patients: so-called "personalised medicine". The aim of this review is to discuss how hyperpolarised (13)C MR spectroscopic imaging might be used for treatment response monitoring. This technique, which increases the sensitivity of detection of injected (13)C-labelled molecules by >10,000-fold, has allowed a new approach to metabolic imaging. The basic principles of the technique and its potential advantages over other imaging methods for detecting early evidence of treatment response will be discussed. Given that the technique is poised to translate to the clinic, I will also speculate on its likely applications.

PMID:
22496072
[PubMed - indexed for MEDLINE]
PMCID:
PMC3474112
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Atypon Icon for PubMed Central
    Loading ...
    Write to the Help Desk